Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will Ascena Retail Group Inc (ASNA) Stand Up to Abercrombie & Fitch Co. (ANF)?

On Wednesday, Ascena Retail Group Inc (NASDAQ:ASNA) will release its latest quarterly results. With retailers having faced a tough winter, however, can Ascena buck the trend and post more promising earnings than some of its peers have?

Ascena Retail Group Inc (NASDAQ:ASNA)

Ascena Retail Group Inc (NASDAQ:ASNA) isn’t a well-known name, but shoppers are familiar with its Dress Barn and Lane Bryant stores. With a big controversy having hit the apparel-retail space during the quarter, Ascena actually stands in a strong position to take full advantage of one of its competitor’s missteps. Let’s take an early look at what’s been happening with Ascena Retail Group Inc (NASDAQ:ASNA) over the past quarter and what we’re likely to see in its quarterly report.

Stats on Ascena

Analyst EPS Estimate $0.31
Change From Year-Ago EPS (8.8%)
Revenue Estimate $1.17 billion
Change From Year-Ago Revenue 49%
Earnings Beats in Past 4 Quarters 3

Source: Yahoo! Finance.

Are Ascena’s earnings ascending this quarter?
Analysts have been fairly optimistic in recent months about Ascena Retail Group Inc (NASDAQ:ASNA)’s earnings prospects, having held their April-quarter estimates steady but boosting their full-year fiscal 2013 calls by $0.03 per share. The stock has positively soared, rising by more than 20% since late February.

Much of the gains in Ascena’s stock came after its earnings report in early March, in which the company managed to do better than investors had expected on both the top and bottom lines. Ascena Retail Group Inc (NASDAQ:ASNA)’s CEO said that he expects tough conditions to continue in the industry, but the company’s moves to cut costs and a nice boost in Internet sales have borne fruit in its financial results.

More recently, though, Ascena got handed a golden opportunity by Abercrombie & Fitch Co. (NYSE:ANF). Abercrombie posted horrible results for its first quarter, with same-store sales plunging 15% driven by bad inventory management. Contributing to Abercrombie & Fitch Co. (NYSE:ANF)’s bad news was the resurfacing of a 2006 interview with CEO Mike Jeffries, in which he offered what many see as a dubious justification for the company’s not offering plus-sized clothing for women. For Ascena’s Lane Bryant, which is arguably the best-known plus-sized fashion brand, the opportunity to cash in on negative publicity from Abercrombie & Fitch Co. (NYSE:ANF) is huge.

Still, a long winter posed challenges for Ascena Retail Group Inc (NASDAQ:ASNA) and its peers. Chico’s FAS, Inc. (NYSE:CHS) plunged last week after falling short of expectations, with the miss coming largely because of weather-related issues that led shoppers not to want to buy warmer-weather fashions during the quarter. Ann Inc (NYSE:ANN)‘s Ann Inc (NYSE:ANN) Taylor stores cited the weather as the reason it boosted promotional discounts at its Loft stores. The same trends might well pose the same trouble for Ascena.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.